Author:
Zheng Dong-hai,Yang Jia-mei,Wu Jian-xiong,Cheng Shu-qun,Zhang Shao-geng,Wu Dong,Li Ai-jun,Fu Xiao-hui,Li Xun,Qi Fu-chen,Duan Wei-hong,Chen Jun-hui,Yang Zhi-ying,Liang Lu,Zeng Jin-xiong,Zheng Wei-da,Wu Meng-chao
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Complementary and alternative medicine,General Medicine
Reference22 articles.
1. Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2021;7:7.
2. Benson AB, D’Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, et al. Guidelines insights: hepatobiliary cancers, version 2. 2019. J Natl Compr Canc Netw 2019;17:302–310.
3. Du Y, Su T, Ding Y, Cao G. Effects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation. Hepat Mon 2012;12:e6031.
4. Dong ZR, Zhang PF, Wang CH, Zhang C, Cai JB, Shi GM, et al. Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinomas beyond the Milan criteria: a retrospective analysis. Am J Cancer Res 2014;5:450–457.
5. Jia F. Progress in diagnosis, treatment, and clinical research of liver cancer in China. Chin J Pract Surg (Chin) 2019;10:17.